Authors: KUDELKA AP LEVY T VERSCHRAEGEN CF EDWARDS CL PIAMSOMBOON S TERMRUNGRUANGLERT W FREEDMAN RS KAPLAN AL KIEBACK DG MEYERS CA JAECKLE KA LOYER E STEGER M MANTE R MAVLIGIT G KILLIAN A TANG RA GUTTERMAN JU KAVANAGH JJ

Citation: Ap. Kudelka et al., A PHASE-I STUDY OF TNP-470 ADMINISTERED TO PATIENTS WITH ADVANCED SQUAMOUS-CELL CANCER OF THE CERVIX, Clinical cancer research, 3(9), 1997, pp. 1501-1505

Authors: HOLMES FA LOPEZ A MAVLIGIT G FRASCHINI G FRYE D HORTOBAGYI GN

Citation: Fa. Holmes et al., SECONDARY DRUG-RESISTANCE IN BREAST-CANCER - FAILURE TO REVERSE WITH ORAL NIFEDIPINE, International journal of cancer, 73(2), 1997, pp. 184-186

Authors: BEDIKIAN AY LEGHA SS MAVLIGIT G CARRASCO CH KHORANA S PLAGER C PAPADOPOULOS N BENJAMIN RS

Citation: Ay. Bedikian et al., TREATMENT OF UVEAL MELANOMA METASTATIC TO THE LIVER - A REVIEW OF THEM-D-ANDERSON-CANCER-CENTER EXPERIENCE AND PROGNOSTIC FACTORS, Cancer, 76(9), 1995, pp. 1665-1670

Authors: ESTROV Z TALPAZ M MAVLIGIT G PAZDUR R HARRIS D GREENBERG SM KURZROCK R

Citation: Z. Estrov et al., ELEVATED PLASMA THROMBOPOIETIC ACTIVITY IN PATIENTS WITH METASTATIC CANCER-RELATED THROMBOCYTOSIS, The American journal of medicine, 98(6), 1995, pp. 551-558